| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGENO.2018.08.011 |
| P698 | PubMed publication ID | 30189225 |
| P2093 | author name string | Hamidreza Mollasalehi | |
| Elmira Shajari | |||
| P2860 | cites work | MicroRNA miR-155 is a biomarker of early pancreatic neoplasia | Q24649254 |
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation | Q24679746 | ||
| Clinical relevance of circulating cell-free microRNAs in ovarian cancer | Q26747154 | ||
| Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening | Q27001043 | ||
| miRNA dysregulation in cancer: towards a mechanistic understanding | Q27026420 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
| Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. | Q33579721 | ||
| Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression | Q34140780 | ||
| Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma | Q34151439 | ||
| Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer | Q34202973 | ||
| Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer | Q34240615 | ||
| Expression of microRNAs in basal cell carcinoma. | Q34271420 | ||
| Non-crosslinking gold nanoprobes for detection of nucleic acid sequence-based amplification products | Q50027710 | ||
| The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | Q50496294 | ||
| Circulating microRNA-196a is an early gastric cancer biomarker. | Q51147595 | ||
| MicroRNA expression profiles in serous ovarian carcinoma. | Q53321694 | ||
| miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. | Q53388648 | ||
| Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. | Q53416418 | ||
| Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening. | Q53536512 | ||
| Prognostic value of miR-106b expression in breast cancer patients. | Q53628965 | ||
| Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. | Q53656768 | ||
| Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. | Q53659259 | ||
| Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. | Q54264657 | ||
| Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis | Q83181319 | ||
| Circulating miRNAs are correlated with tumor progression in prostate cancer | Q84232903 | ||
| Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma | Q84546774 | ||
| Plasma miR-21: a potential diagnostic marker of colorectal cancer | Q84740946 | ||
| MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer | Q86892940 | ||
| The role of MicroRNAs in human cancer | Q89700410 | ||
| Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients | Q95567834 | ||
| The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer | Q34273062 | ||
| Serum microRNA-155 as a potential biomarker to track disease in breast cancer | Q34447755 | ||
| The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. | Q34806020 | ||
| miR-21: a small multi-faceted RNA. | Q34931601 | ||
| Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer | Q35040690 | ||
| MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. | Q35053331 | ||
| Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma | Q35063395 | ||
| Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma | Q35108381 | ||
| MicroRNA alterations in head and neck squamous cell carcinoma. | Q35253630 | ||
| miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. | Q35475274 | ||
| Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | Q35623347 | ||
| De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer | Q35927834 | ||
| Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer | Q36594062 | ||
| Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort | Q36997902 | ||
| Serum circulating microRNA profiling for identification of potential breast cancer biomarkers | Q37260646 | ||
| Higher expression of circulating miR-182 as a novel biomarker for breast cancer | Q37326193 | ||
| The microRNA-17-92 family of microRNA clusters in development and disease | Q38014608 | ||
| The emerging role of miR-375 in cancer | Q38156047 | ||
| Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids | Q38264253 | ||
| miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma | Q38320511 | ||
| Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer | Q39015764 | ||
| Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer | Q39036116 | ||
| Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma | Q39167703 | ||
| MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. | Q39176725 | ||
| Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women. | Q39274433 | ||
| Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. | Q39452081 | ||
| Circulating microRNAs in plasma of patients with gastric cancers | Q39986294 | ||
| miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma | Q40263123 | ||
| Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer | Q42112822 | ||
| Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. | Q42233721 | ||
| Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. | Q42267974 | ||
| Identification of circulating microRNA signatures for breast cancer detection | Q43511958 | ||
| Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer | Q43873674 | ||
| Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening | Q45355708 | ||
| Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis. | Q47109479 | ||
| An improved non-crosslinking gold nanoprobe-NASBA based on 16S rRNA for rapid discriminative bio-sensing of major salmonellosis pathogens | Q50016614 | ||
| Development and evaluation of a novel nucleic acid sequence-based amplification method using one specific primer and one degenerate primer for simultaneous detection of Salmonella Enteritidis and Salmonella Typhimurium | Q50017425 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 163-168 | |
| P577 | publication date | 2018-09-04 | |
| P1433 | published in | Genomics | Q5533503 |
| P1476 | title | Ribonucleic-acid-biomarker candidates for early-phase group detection of common cancers | |
| P478 | volume | 112 |
| Q93155184 | Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization | cites work | P2860 |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.